Conventional or endovascular treatment of ongoing mycotic aortic aneurysmal disease?

Kirsten Kuizenga, Michel M.P.J. Reijnen, Ignace F.J. Tielliu, Eric L.G. Verhoeven, Jan J.A.M. Van den Dungen, Clark J. Zeebregts* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)


We report a case in which conventional and endovascular exclusion techniques were used to treat ongoing mycotic aortic aneurysmal disease. A 51-year-old man presented with an infrarenal mycotic aortic aneurysm that was excluded and reconstructed with a superficial femoral vein. Two years later, he developed a symptomatic mycotic aneurysm of the descending thoracic aorta, which required emergent treatment with a stent graft. The patient died 5 months later of massive bleeding owing to an aortobronchial fistula deriving from a new thoracic aneurysm proximal to the stent graft. Choices and different modes of treatment are discussed. Endovascular treatment of symptomatic mycotic aortic aneurysm might provide a valid alternative to open repair but may be unsuccessful owing to ongoing infection. In situ replacement using autologous material seems appealing whenever feasible.

Original languageEnglish
Pages (from-to)103-107
Number of pages5
Issue number2
Publication statusPublished - 2 Nov 2009
Externally publishedYes


  • Aneurysm
  • Aortic
  • Endovascular aneursym repair
  • Mycotic
  • Stent graft
  • Superficial femoral vein


Dive into the research topics of 'Conventional or endovascular treatment of ongoing mycotic aortic aneurysmal disease?'. Together they form a unique fingerprint.

Cite this